Meiling Cheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Meiling Cheng has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Liyi Yu
Computer Department, Jingdezhen Ceramic University, Jingdezhen 333403, China
1 shared publication - Wang-Ren Qiu
School of Information Engineering, Jingdezhen Ceramic University, Jingdezhen, China
1 shared publication - Weizhong Lin
Affiliation School of Information Engineering, Jingdezhen Ceramic University, Jingdezhen Jiangxi, China
1 shared publication - Xuan Xiao
School of Information Engineering, Jingdezhen Ceramic University, Jingdezhen, China
1 shared publication - Zhaochun Xu
School of Interdisciplinary Medicine and Engineering, Harbin Medical University , 157 Baojian Road, Nangang District, Harbin 150081, Heilongjiang Province
1 shared publication
Latest Publications
- Open Access
- 24 February 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (5) , 4500
MSEDDI: Multi-Scale Embedding for Predicting Drug—Drug Interaction Events
A norm in modern medicine is to prescribe polypharmacy to treat disease. The core concern with the co-administration of drugs is that it may produce adverse drug—drug interaction (DDI), which can cause unexpected bodily injury. Therefore, it is essential to identify potential DDI. Most existing methods in silico only judge whether two drugs interact, ignoring the importance of interaction events to study the mechanism implied in combination drugs. In this work, we propose a deep learning framework named MSEDDI that comprehensively considers multi-scale embedding representations of the drug for predicting drug—drug interaction events. In MSEDDI, we design three-channel networks to process biomedical network-based knowledge graph embedding, SMILES sequence-based notation embedding, and molecular graph-based chemical structure embedding, respectively. Finally, we fuse three heterogeneous features from channel outputs through a self-attention mechanism and feed them to the linear layer predictor. In the experimental section, we evaluate the performance of all methods on two different prediction tasks on two datasets. The results show that MSEDDI outperforms other state-of-the-art baselines. Moreover, we also reveal the stable performance of our model in a broader sample set via case studies.
- 24 February 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (5) , 4500
Open AccessMSEDDI: Multi-Scale Embedding for Predicting Drug—Drug Interaction Events
A norm in modern medicine is to prescribe polypharmacy to treat disease. The core concern with the co-administration of drugs is that it may produce adverse drug—drug interaction (DDI), which can cause unexpected bodily injury. Therefore, it is essential to identify potential DDI. Most existing methods in silico only judge whether two drugs interact, ignoring the importance of interaction events to study the mechanism implied in combination drugs. In this work, we propose a deep learning framework named MSEDDI that comprehensively considers multi-scale embedding representations of the drug for predicting drug—drug interaction events. In MSEDDI, we design three-channel networks to process biomedical network-based knowledge graph embedding, SMILES sequence-based notation embedding, and molecular graph-based chemical structure embedding, respectively. Finally, we fuse three heterogeneous features from channel outputs through a self-attention mechanism and feed them to the linear layer predictor. In the experimental section, we evaluate the performance of all methods on two different prediction tasks on two datasets. The results show that MSEDDI outperforms other state-of-the-art baselines. Moreover, we also reveal the stable performance of our model in a broader sample set via case studies.